{"organizations": [], "uuid": "7bb5f1d01e983a78a0565999ddca796eefbb0419", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/RegeneRx-Receives--24500-000-Milestone-Payment-With-Enrollment-of-First-Patient-in-U-S--Phase-2b-3-Dry-Eye-Trial-48502-1/", "country": "US", "title": "RegeneRx Receives $500,000 Milestone Payment With Enrollment of First Patient in U.S. Phase 2b/3 Dry Eye Trial", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "RegeneRx Receives $500,000 Milestone Payment With Enrollment of First Patient in U.S. Phase 2b/3 Dry Eye Trial", "spam_score": 0.0, "site_type": "news", "published": "2015-09-30T21:21:00.000+03:00", "replies_count": 0, "uuid": "7bb5f1d01e983a78a0565999ddca796eefbb0419"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/RegeneRx-Receives--24500-000-Milestone-Payment-With-Enrollment-of-First-Patient-in-U-S--Phase-2b-3-Dry-Eye-Trial-48502-1/", "ord_in_thread": 0, "title": "RegeneRx Receives $500,000 Milestone Payment With Enrollment of First Patient in U.S. Phase 2b/3 Dry Eye Trial", "locations": ["U.S."], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2015-09-30T21:21:00.000+03:00", "crawled": "2015-09-30T23:29:25.960+03:00", "highlightTitle": ""}